Funder
Shahid Beheshti University of Medical Sciences
Reference115 articles.
1. A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer;Ahn;Cancer Chemother. Pharmacol.,2014
2. PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome;Alsaab;Front. Pharmacol.,2017
3. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation;Anderson;Immunity,2016
4. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma;Ansell;N. Engl. J. Med.,2015
5. Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study;Antonia;Lancet Oncol,2016
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献